Epicin RD 10mg Injection
Marketer
Vhb Life Sciences Inc
Salt Composition
Epirubicin (10mg)
Overview Epicin RD 10mg Injection
Rydacin 10mg intravenous injection treats various blood cancers, as well as cancers affecting the breast, stomach, lung, ovaries, and soft tissues. It also aids in preventing bladder cancer recurrence post-surgery. Administered intravenously by a healthcare professional, it may be used alone or in combination with other medications as part of a chemotherapy regimen. Dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdosage can lead to severe adverse effects. Therapeutic benefits might not be apparent immediately, potentially taking weeks or months; discontinue use only under your doctor's guidance. This medication may reduce the effectiveness of oral contraceptives, necessitating reliable birth control for both partners during treatment. Common side effects include nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and dermatological reactions. Reduced blood cell counts increase infection risk, potentially life-threatening. Regular blood tests to monitor blood cell counts, and kidney, liver, and heart function are crucial. Prior to treatment, disclose any pre-existing liver or heart conditions, and inform your doctor of all other medications you are taking, as interactions may compromise efficacy or alter the drug's action. Disclose pregnancy or breastfeeding status to your physician.
Uses of Epicin RD 10mg Injection
Malignant neoplasm
Major Benefits of Epicin RD 10mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Epicin RD 10mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Epicin RD 10mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Epicin RD 10mg Injection works:
RD-10 Epicin injection, an anticancer agent, inhibits topoisomerase II, a key enzyme in breast cancer cell DNA replication. This action, coupled with the generation of cytotoxic free radicals, damages cancerous DNA, thus impeding tumor growth and leading to cell death.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Epicin RD 10mg Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Epicin RD 10mg Injection during pregnancy is contraindicated due to established harm to the fetus. Exceptions may exist in critical circumstances where the physician deems the potential benefits outweigh the risks. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Epicin RD 10mg Injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Administering Epicin RD 10mg Injection may result in adverse reactions that could compromise driving capabilities. These reactions can include nausea and vomiting, temporarily hindering safe operation of a vehicle.
KidneySAFE IF PRESCRIBED
The use of Epicin RD 10mg Injection in individuals with kidney impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary; however, physician consultation is advised. For patients exhibiting serum creatinine exceeding 5 mg/dL, reduced dosages should be explored.
LiverCAUTION
Patients with liver impairment should receive Epicin RD 10mg Injection cautiously, potentially requiring dose modification. Physician consultation is advised. Epicin RD 10mg Injection is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Epicin RD 10mg Injection :
NA
Facts to Know About Epicin RD 10mg Injection
| Label | Value |
|---|---|
| Chemical Category | Anthracycline-based drug |
| Developing Habits | No. |
| Type of Therapy | Cancer Therapeutics |
| Behavioral Class | Cytotoxic alkaloids |
3,018 People bought this recently